Page last updated: 2024-08-24

2-methoxyestradiol and Argentaffinoma

2-methoxyestradiol has been researched along with Argentaffinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abrams, TA; Blaszkowsky, LS; Chan, JA; Fuchs, CS; Kulke, MH; Meyerhardt, JA; Regan, E; Sidor, C; Zhu, AX	1

Trials

1 trial(s) available for 2-methoxyestradiol and Argentaffinoma

Article	Year
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:2 Topics: 2-Methoxyestradiol; Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoid Tumor; Cohort Studies; Estradiol; Female; Gastrointestinal Neoplasms; Humans; Hydroxyestrones; Male; Middle Aged; Neoplasm Staging; Patient Dropouts; Survival Analysis; Tumor Burden; Vascular Endothelial Growth Factor A	2011

Article

Year

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.

Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:2

Topics: 2-Methoxyestradiol; Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoid Tumor; Cohort Studies; Estradiol; Female; Gastrointestinal Neoplasms; Humans; Hydroxyestrones; Male; Middle Aged; Neoplasm Staging; Patient Dropouts; Survival Analysis; Tumor Burden; Vascular Endothelial Growth Factor A

2011